Li Weihong, Sciallis Andrew, Lew Madelyn, Pang Judy, Jing Xin
Department of Pathology, The University of Michigan Health System, Ann Arbor, Michigan.
Diagn Cytopathol. 2018 Feb;46(2):148-153. doi: 10.1002/dc.23866. Epub 2017 Nov 30.
Noninvasive encapsulated follicular variant of papillary thyroid carcinoma (PTC) has recently been reclassified as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Implementation of the new terminology may alter the implied risk of malignancy (ROM) across the six categories of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
The study cohort consisted of thyroid fine needle aspiration (FNA) cases which were assessed between January 2011 and June 2016 and led to surgical resections. For each case, patient demographics as well as cytologic and corresponding histologic diagnoses were recorded. The surgical specimens diagnosed as follicular variant of PTC (FVPTC) were re-reviewed to identify cases that met the diagnostic criteria for NIFTP. The ROM with and without exclusion of NIFTP from malignant categorization, as well as the relative change in ROM were calculated for individual categories of TBSRTC.
A total of 908 FNA cases with surgical follow-up were retrieved and PTC was identified in 252 (27.8%) surgical specimens. Twenty-nine of 252 (11.5%) were initially classified as FVPTC, of which 17 (6.7%) were reclassified as NIFTP. The cytologic interpretations for the majority of NIFTP cases were atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS, n = 8) or follicular neoplasm/suspicious for neoplasm/(FN/SFN, n = 4). Excluding NIFTP from malignant categorization resulted in a relative decrease in ROM in AUS/FLUS (25.8%) and FN/SFN (22.3%) categories.
Our institutional data demonstrates that eliminating NIFTP from malignant categorization may result in a reduction of the implied ROM for AUS/FLUS and FN/SFN categories.
甲状腺乳头状癌(PTC)的非侵袭性包裹性滤泡变体最近被重新分类为具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)。新术语的实施可能会改变甲状腺细胞病理学报告贝塞斯达系统(TBSRTC)六个类别的隐含恶性风险(ROM)。
研究队列包括2011年1月至2016年6月期间接受评估并导致手术切除的甲状腺细针穿刺(FNA)病例。记录每个病例的患者人口统计学信息以及细胞学和相应的组织学诊断。对诊断为PTC滤泡变体(FVPTC)的手术标本进行重新审查,以确定符合NIFTP诊断标准的病例。计算了TBSRTC各个类别的包含和不包含NIFTP的恶性分类的ROM,以及ROM的相对变化。
共检索到908例有手术随访的FNA病例,252例(27.8%)手术标本中确诊为PTC。252例中有29例(11.5%)最初被分类为FVPTC,其中17例(6.7%)被重新分类为NIFTP。大多数NIFTP病例的细胞学解释为意义不明确的非典型性/意义不明确的滤泡性病变(AUS/FLUS;n = 8)或滤泡性肿瘤/可疑肿瘤(FN/SFN;n = 4)。将NIFTP排除在恶性分类之外导致AUS/FLUS(25.8%)和FN/SFN(22.3%)类别中的ROM相对降低。
我们机构的数据表明,将NIFTP从恶性分类中排除可能会降低AUS/FLUS和FN/SFN类别的隐含ROM。